The latter seems to be an important mechanism in pancreatic cancer, because expression of KLK10 itself could not be associated with poor survival in PDAC, whereas the co-expression of both kallikreins was significantly associated with poor survival and an R1-resection status, which is an indirect sign for infiltrative and aggressive growth. Here, KLK4 is linked to pancreatic neoplasm.